The next opportunity in anti-malaria drug discovery: The liver stage

PLoS Pathogens

Volumn 7, Issue 9, 2011, Pages

  Derbyshire, Emily R ^a   Mota, Maria M ^b   Clardy, Jon ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ATOVAQUONE; CHINESE DRUG; PRIMAQUINE; ARTEMISININ DERIVATIVE; CHLOROQUINE;

ARTICLE; DRUG DEVELOPMENT; ERYTHROCYTE; HUMAN; LIVER; MALARIA; MEROZOITE; NONHUMAN; PLASMODIUM CYNOMOLGI; PLASMODIUM FALCIPARUM; PLASMODIUM OVALE; PLASMODIUM VIVAX; SPOROZOITE; ANTIBIOTIC RESISTANCE; DRUG EFFECT; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM MALARIAE;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG DISCOVERY; DRUG RESISTANCE, MICROBIAL; HUMANS; LIVER; MALARIA; PLASMODIUM MALARIAE;

EID: 80053494971     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002178     Document Type: Article

References (53)

1. Carter R, Mendis KN, (2002) Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev 15: 564-594.
2. Sachs J, Malaney P, (2002) The economic and social burden of malaria. Nature 415: 680-685.
3. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
4. Wolrd Health Organization. (2010) World Malaria Report 2010.
5. Prudencio M, Rodriguez A, Mota MM, (2006) The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol 4: 849-856.
6. Mendis K, Sina BJ, Marchesini P, Carter R, (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106.
7. Bassat Q, Alonso PL, (2011) Defying malaria: fathoming severe Plasmodium vivax disease. Nat Med 17: 48-49.
8. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, et al. (2007) Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79-87.
9. Wells TN, Burrows JN, Baird JK, (2010) Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol 26: 145-151.
10. Baird JK, (2005) Effectiveness of antimalarial drugs. N Engl J Med 352: 1565-1577.
11. Dondorp AM, Yeung S, White L, Nguon C, Day NP, et al. (2010) Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 8: 272-280.
12. Mazier D, Renia L, Snounou G, (2009) A pre-emptive strike against malaria's stealthy hepatic forms. Nat Rev Drug Discov 8: 854-864.
13. White NJ, (2004) Antimalarial drug resistance. J Clin Invest 113: 1084-1092.
14. Gardner MJ, Hall N, Fung E, White O, Berriman M, et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498-511.
15. Patel V, Mazitschek R, Coleman B, Nguyen C, Urgaonkar S, et al. (2009) Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. J Med Chem 52: 2185-2187.
16. Sriwilaijaroen N, Boonma S, Attasart P, Pothikasikorn J, Panyim S, et al. (2009) Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase. Biochem Biophys Res Commun 381: 144-147.
17. Baldwin J, Michnoff CH, Malmquist NA, White J, Roth MG, et al. (2005) High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J Biol Chem 280: 21847-21853.
18. Booker ML, Bastos CM, Kramer ML, Barker RH Jr, Skerlj R, et al. (2010) Novel inhibitors of plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model. J Biol Chem 285: 33054-33064.
19. Brobey RK, Sano G, Itoh F, Aso K, Kimura M, et al. (1996) Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials. Mol Biochem Parasitol 81: 225-237.
20. Lee PJ, Bhonsle JB, Gaona HW, Huddler DP, Heady TN, et al. (2009) Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. J Med Chem 52: 952-963.
21. Sharma S, Sharma SK, Modak R, Karmodiya K, Surolia N, et al. (2007) Mass spectrometry-based systems approach for identification of inhibitors of Plasmodium falciparum fatty acid synthase. Antimicrob Agents Chemother 51: 2552-2558.
22. Baniecki ML, Wirth DF, Clardy J, (2007) High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob Agents Chemother 51: 716-723.
23. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, et al. (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465: 305-310.
24. Goonewardene R, Daily J, Kaslow D, Sullivan TJ, Duffy P, et al. (1993) Transfection of the malaria parasite and expression of firefly luciferase. Proc Natl Acad Sci U S A 90: 5234-5236.
25. Cervantes S, Prudhomme J, Carter D, Gopi KG, Li Q, et al. (2009) High-content live cell imaging with RNA probes: advancements in high-throughput antimalarial drug discovery. BMC Cell Biol 10: 45.
26. Ecker A, Moon R, Sinden RE, Billker O, (2006) Generation of gene targeting constructs for Plasmodium berghei by a PCR-based method amenable to high throughput applications. Mol Biochem Parasitol 145: 265-268.
27. Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, et al. (2010) Chemical genetics of Plasmodium falciparum. Nature 465: 311-315.
28. Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, et al. (2010) Spiroindolones, a potent compound class for the treatment of malaria. Science 329: 1175-1180.
29. Basco LK, Bickii J, Ringwald P, (1999) In-vitro activity of primaquine against the asexual blood stages of Plasmodium falciparum. Ann Trop Med Parasitol 93: 179-182.
30. Bray PG, Deed S, Fox E, Kalkanidis M, Mungthin M, et al. (2005) Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum. Biochem Pharmacol 70: 1158-1166.
31. Baird JK, Hoffman SL, (2004) Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345.
32. Cappellini MD, Fiorelli G, (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371: 64-74.
33. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, et al. (2003) Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301: 1503-1508.
34. Westenberger SJ, McClean CM, Chattopadhyay R, Dharia NV, Carlton JM, et al. (2010) A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis 4: e653 doi:10.1371/journal.pntd.0000653.
35. Williams CT, Azad AF, (2010) Transcriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoelii. PLoS ONE 5: e10267 doi:10.1371/journal.pone.0010267.
36. Kappe SH, Duffy PE, (2006) Malaria liver stage culture: in vitro veritas? Am J Trop Med Hyg 74: 706-707.
37. Calvo-Calle JM, Moreno A, Eling WM, Nardin EH, (1994) In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines. Exp Parasitol 79: 362-373.
38. Hollingdale MR, Leef JL, McCullough M, Beaudoin RL, (1981) In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei from sporozoites. Science 213: 1021-1022.
39. Mazier D, Beaudoin RL, Mellouk S, Druilhe P, Texier B, et al. (1985) Complete development of hepatic stages of Plasmodium falciparum in vitro. Science 227: 440-442.
40. Bruna-Romero O, Hafalla JC, Gonzalez-Aseguinolaza G, Sano G, Tsuji M, et al. (2001) Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int J Parasitol 31: 1499-1502.
41. Witney AA, Doolan DL, Anthony RM, Weiss WR, Hoffman SL, et al. (2001) Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy. Mol Biochem Parasitol 118: 233-245.
42. Natarajan R, Thathy V, Mota MM, Hafalla JC, Menard R, et al. (2001) Fluorescent Plasmodium berghei sporozoites and pre-erythrocytic stages: a new tool to study mosquito and mammalian host interactions with malaria parasites. Cell Microbiol 3: 371-379.
43. Tarun AS, Baer K, Dumpit RF, Gray S, Lejarcegui N, et al. (2006) Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol 36: 1283-1293.
44. Prudencio M, Rodrigues CD, Ataide R, Mota MM, (2008) Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cell Microbiol 10: 218-224.
45. Gego A, Silvie O, Franetich JF, Farhati K, Hannoun L, et al. (2006) New approach for high-throughput screening of drug activity on Plasmodium liver stages. Antimicrob Agents Chemother 50: 1586-1589.
46. Prudencio M, Rodrigues CD, Hannus M, Martin C, Real E, et al. (2008) Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog 4: e1000201 doi:10.1371/journal.ppat.1000201.
47. Rodrigues CD, Hannus M, Prudencio M, Martin C, Goncalves LA, et al. (2008) Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe 4: 271-282.
48. Mwakingwe A, Ting LM, Hochman S, Chen J, Sinnis P, et al. (2009) Noninvasive real-time monitoring of liver-stage development of bioluminescent Plasmodium parasites. J Infect Dis 200: 1470-1478.
49. Ploemen IH, Prudencio M, Douradinha BG, Ramesar J, Fonager J, et al. (2009) Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS ONE 4: e7881 doi:10.1371/journal.pone.0007881.
50. Chattopadhyay R, Velmurugan S, Chakiath C, Andrews Donkor L, Milhous W, et al. (2010) Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. PLoS ONE 5: e14275 doi:10.1371/journal.pone.0014275.
51. Dembele L, Gego A, Zeeman AM, Franetich JF, Silvie O, et al. (2011) Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS ONE 6: e18162 doi:10.1371/journal.pone.0018162.
52. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, et al. (2008) A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci U S A 105: 305-310.
53. Hall N, Karras M, Raine JD, Carlton JM, Kooij TW, et al. (2005) A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 307: 82-86.